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OBJECTIVES: A duplex ultrasound study was performed to investigate morphological and hemodynamic patterns of
carotid stenoses treated by endarterectomy with patch closure versus stenting.
MATERIALS AND METHOD: Twenty-nine carotid stenoses were treated with stenting and 65 with patch closure.
Duplex ultrasound parameters (luminal diameter, mm; peak systolic velocity and end-diastolic velocity, cm/s) were
measured 24 hours after the procedures and also at 12 months post-procedure. Residual stenoses (immediately post-
procedure) and restenoses (within 12 months of procedure) were defined as narrowings of $50% on duplex
ultrasound examination.
RESULTS: In stented patients, the luminal diameter of the proximal internal carotid artery increased in the interval
between the 24-hour and 12-month post-procedure studies, while in the patch closure patients, the diameter
decreased. Carotid hemodynamics normalized immediately after both patching and stenting and remained
relatively stable thereafter up to 12 months. No statistically elevated flow velocities (in the absence of residual
stenosis or restenosis) were observed in the patched or stented carotid arteries. No significant differences in residual
stenosis rates were observed between the stenting group (3 cases, 10.34%) and the patch closure group (1 case,
1.53%, P = 0.08). At 12 months, 2 stenting patients (6.88%) and 2 patch closure patients (3.07%) had $50%
restenosis (P = 0.58). One case of late stroke due to restenosis was observed in the stenting group; the patient died
12 months postoperatively, before receiving new intervention.
CONCLUSION: Measurements over time in luminal diameter signalized differences in arterial remodeling
mechanisms between patched and stented carotids. Both stenting and patch closure were associated with carotid
patency and flow restoration. This study does not support a general approach to new velocity criteria
indiscriminately applied to stented or patched carotids.
KEYWORDS: Bovine pericardial patch angioplasty; Carotid artery stenosis; Carotid endarterectomy; Carotid
stenting; Duplex ultrasound.
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INTRODUCTION
Carotid endarterectomy with patch closure and carotid
artery stenting with embolic protection are therapeutic
approaches for the prevention of stroke and transient
ischemic attack (TIA) in patients with moderate to severe
symptomatic and asymptomatic carotid artery stenosis.
1-9
The efficacy of both patch closure and carotid artery
stenting is highly dependent on low procedural morbidity
and producing a durable repair with a low incidence of
recurrent stenosis or occlusion.
As duplex ultrasound (DUS) provides detailed informa-
tion of the extracranial carotid bifurcation, many vascular
laboratories have adopted a policy of DUS surveillance to
confirm carotid patency and grade residual stenosis, and
restenosis severity after patch closure and stenting. In
general, DUS examination is largely based on analysis of
the peak systolic velocity (PSV) and the end-diastolic
velocity (EDV).
10-14 However, there is no consensus regard-
ing the threshold criteria for the interpretation of DUS
results after patching and stenting, and the performance of
carotid DUS varies considerably from laboratory to labora-
tory. Some groups,
15-17 including our own, have used a DUS
algorithm validated for native (nonoperated) carotid arteries
Copyright  2010 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
CLINICS 2010;65(12):1315-1323 DOI:10.1590/S1807-59322010001200015
1315in the follow-up of patch closure and carotid artery stenting,
whereas other groups
18-28 have emphasized that patched
and stented carotids are best evaluated by revised velocity
criteria.
Previous clinical studies reported flow disturbances in the
internal carotid artery (ICA) in patients undergoing patch
closure or carotid artery stenting,
26,29,30 supporting the idea
that velocity thresholds for patched and stented carotids
may need revision. However, many of the hemodynamic
studies following patch closure and carotid artery stenting
have been performed on patients in diverse post-procedural
periods. Therefore, it is possible that velocity profiles related
to treated site arterial remodeling and/or biomechanical
changes present distinct alterations as a function of time,
thereby potentially biasing the results. Furthermore, in the
studies comparing velocity profiles and morphological
measurements, the analyses could not be performed across
the full spectrum of the degree of restenosis. DUS
parameters of patched and stented carotids and how they
relate to patient outcome are not yet well defined.
In this study, our group investigated the effects of
stenting and patching on carotid morphological and
hemodynamic DUS parameters measured 24 hours post-
procedure and at 12 months post-procedure. In addition,
our experience using previously validated criteria for native
carotids and its application to patch closure and carotid
artery stenting is detailed in this study. New clinical events
were recorded during and after the procedures (20-month
surveillance period), as were deaths and the causes of death.
DUS and clinical outcomes obtained for stenting were
compared with patch closure.
MATERIALS AND METHOD
Patient population
Between May 2005 and May 2007, 131 patients under-
going 139 carotid procedures (patch closure or stenting)
were prospectively entered into a nonrandomized study.
Our protocol complied with Declaration of Helsinki and
was approved by the Institutional Ethics Committee, and
written informed consent was obtained from all patients.
Of the 139 carotids, 94 with asymptomatic ($70%) or
symptomatic ($50%) carotid bifurcation atherosclerotic
stenoses were admitted in this protocol. The severity of
carotid bifurcation stenosis was evaluated on DUS validated
against subtraction angiography, computed tomographic
angiography or magnetic resonance angiography. Patients
facing additional myocardial revascularization and who had
carotids with radiation-induced or fibromuscular dysplasia,
or recurrent stenoses were not included in the study.
Patients were excluded if they did not undergo post-
operative DUS because of the unavailability of the vascular
radiologist (all examinations were performed by a single
vascular radiologist), or because of technical difficulties.
Carotid artery stenting was offered to 29 patients. The
selection of 18 patients from our practice was based on the
presence of either anatomic high risk [carotid bifurcation
above C2 level, n = 8; previous cervical surgery, n = 3; con-
comitant intracranial stenosis, n = 1; common carotid artery
(CCA) plaque, n = 1] or high medical risk (coronary artery
disease, n = 2; peripheral arterial disease, n = 2; chronic
obstructive pulmonary disease, n = 1). Eleven normal-risk
patients in the stenting group were referred from other
physicians specifically for endovascular management. The
mean age of stenting patients was 68.9 ¡ 8.25 years, and
there was a higher number of male patients (25 men and 4
women). Twenty-two cases were asymptomatic and 7 were
symptomatic.
Sixty-five carotid bifurcation stenoses in 39 asymptomatic
and 26 symptomatic patients were treated with patch
closure (50 men, 15 women; mean age, 69.7 ¡ 10.33 years).
Patient demographics, carotid bifurcation status, risk
factors and clinical symptoms at the time of procedure are
shown in Table 1. The patch closure and stenting groups
were similar in all aspects with the exception that there were
significantly more patients with coronary artery disease
(65.51%) and peripheral arterial disease (62.06%) in the
carotid artery stenting group than in the patch closure
group (43.07% and 29.23%, respectively).
Protected-carotid artery stenting
Carotid artery stenting was performed by a single team of
vascular surgeons and interventional radiologists using a
standardized protocol. All stentings were performed under
local anesthesia and via a retrograde access from the
common femoral artery. Anticoagulation was assured by
the administration of heparin (100 UI/kg). Protective filters
(EPI filter EZ, Boston Scientific, Natick, MA, USA) were
used in all cases. A self-expanding WallstentH (Boston
Scientific) was deployed in all cases in the ICA with
extension into the CCA (the diameter and length of the
most frequently used stent was 7 mm 6 40 mm).
Deployment was followed by in-stent dilatation using a
balloon catheter (Boston Scientific). No heparin reversal was
performed. All patients received combined platelet inhibi-
tion with aspirin (100 mg) and clopidogrel (75 mg) for at
least 1 week preoperatively and for 3 months postopera-
tively.
Carotid endarterectomy with bovine patch closure
Carotid endarterectomy was performed by a single
vascular surgeon using a standardized method (longitudi-
nal arteriotomy). All patients were administered general
anesthesia. Selective shunting (Edwards Lifesciences LLC,
Irvine, CA, USA) was used in 24 operations (37%). The
shunt criteria were: presence of contralateral severe stenosis
(.60%) or occlusion (11 cases, 46%); history of recent stroke
(6 cases, 25%); anatomical variations resulting in abnormal
physiology of the Willis circle (3 cases, 12.5%); technical
difficulties for the performance of the surgical procedures (2
cases, 8.3%); requirement of extension of the proximal or
distal arteriotomy (use of balloon shunt) (2 cases, 8.3%).
In all cases, intravenous heparin was administered before
carotid clamping and activated clotting time was main-
tained in the range of 200 to 250 seconds throughout the
operation. The arteriotomy was closed with a bovine
pericardial patch angioplasty with a continuous suture
technique. All patches were 8 mm wide and manufacturer-
designed (Braile Biome ´dica Ind. e Com. Rep. S/A, Sa ˜o Jose ´
do Rio Preto, Sa ˜o Paulo, Brazil). Preoperative imaging data
concerning the vessel dimensions, manufacturer specifica-
tions and technical data, and observations from previous
experience, were all considered when standardizing the
patch diameter to 8 mm. Here, standardization contributed
to reducing the bias in the postoperative DUS measure-
ments. The systemic heparinization was reversed with
protamine chloride. Preoperatively, all patients received
100 mg aspirin daily which was then continued for life.
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All carotids were examined with a Philips/ATL HDI 5000
scanner (Philips, Bothell, WA, USA) operated by a single
registered vascular radiologist. Morphological (luminal
diameter, mm) and hemodynamic (PSV and EDV, cm/s)
parameters were measured 1 day before the procedure and
at 24 hours and 12 months post-procedure. All DUS
examinations were performed using an algorithm validated
for preoperative carotid arteries.
14 Stenoses of $50% were
defined by a PSV of $125 cm/s and an EDV of 40 to 100 cm/
s. Peak systolic velocities of $230 cm/s and an EDV of $100
indentified $70% stenosis. Lesions that generated an EDV
of $140 cm/s were interpreted as $80% stenosis.
14
Additional information derived from B-mode imaging and
spectral broadening was used to supplement the velocity
criteria to determine stenosis severity.
The examinations included insonation of CCA, proximal
ICA (p-ICA) and distal ICA (d-ICA), which were studied in
the sagital and transverse planes. The p-ICA was defined as a
2 cm segment beginning at the origin of the external carotid
artery. In the d-ICA, the postoperative DUS parameters were
measured immediately distal to the patch or stent, except
when the area of transition between the native d-ICA and the
distal end of the stent was not visualized on B-mode. In these
cases, the DUS measurements were performed at the level of
the most distal signal of blood flow. The angle of insonation
used to obtain B-mode images was near 90 degrees. The
Doppler curve was obtained with an angle of insonationof 60
degrees or less when using angle correction.
Residual stenoses (immediately post-procedure) and
restenoses (within 12 months of procedure) were defined
as narrowings of $50% on DUS examination.
31-34 Greater
than 70% restenoses were confirmed using subtraction
angiography.
Clinical evaluation
New clinical events were recorded during and after the
procedures (20-month surveillance period), as were deaths
and causes of death. Stroke was defined as an acute
disturbance of focal neurological function with symptoms
lasting longer than 24 hours and TIA was defined as a new
neurological event that lasted less than 24 hours. All cases
with clear or suspected neurological symptoms were
evaluated by an independent neurologist. When a neurolo-
gical deficit was encountered, computed tomography was
used to define the cause of the event. Patients were
instructed to inform the physician when any new symptoms
occurred after hospital discharge. All patients were
followed-up at 3 and 6 months postoperatively, and at 6-
month intervals thereafter.
Statistical analysis
Continuous values are presented as mean ¡ standard
deviation (SD) and nominal data as count and percentages.
For comparisons of clinical outcomes, the Chi-square test
with Yates correction and Fisher’s exact test were used. The
Kaplan-Meier method was used to estimate patient survival
after the procedures. Short-term morphologic and hemody-
namic parameters of both carotid artery stenting and patch
closure were assessed by comparing DUS results obtained
immediately postoperatively with preoperative DUS.
Similarly, late DUS parameters were assessed by comparing
the results from postoperative day 1 with 12 months
postoperative. All comparisons between two DUS were
done using paired sampled t-tests. The tests were per-
formed at a significance level of ,0.05. All calculations and
statistical comparisons were performed using Minitab 12
TM
(State College, PA, USA) and MedCalc 9.3 (MedCalc Inc,
Mariakerke, Belgium).
Table 1 – Baseline characteristics of patients according to treatments.
Variable Stenting group Patch closure group P-value
n˚ of procedures 29 65
n˚ asymptomatic patients 22 (75.86) 39 (60) 0.20
n˚ symptomatic patients 07 (20.75) 26 (40) 0.20
male/female 25/4 50/15 0.40
mean age ¡ SD (range) 68.9 ¡ 8.25 (57-94) 69.7 ¡ 10.33 (44-88) 0.73
statin 15 (51.42) 27 (41.53) 0.48
Risk factors
coronary artery disease 19 (65.51) 28 (43.07) 0.00*
chronic renal disease 03 (10.34) 03 (4.61) 0.36
diabetes mellitus 11 (37.93) 13 (20.0) 0.11
dyslipidemia 22 (75.86) 40 (61.53) 0.26
peripheral arterial disease 18 (62.06) 19 (29.23) 0.00*
nicotine abuse 18 (62.06) 36 (55.38) 0.70
systemic arterial hypertension 26 (89.65) 58 (89.23) 0.76
Carotid status 0.80
50-69% stenosis 05 (17.24) 14 (21.53) -
70-99% stenosis 17 (58.62) 36 (55.38) -
ICA near-occlusion 05 (17.24) 13 (20) -
calcific shadow 02 (6.80) 02 (3.07) -
Clinical symptoms
amaurosis fugax 0 02 (3.07) 1
contralateral ICA stenosis ($50%) 17 (58.62) 27 (41.53) 0.19
stroke 04 (13.79) 15 (23.07) 0.40
transient ischemic attack 03 (10.34) 09 (13.84) 0.74
Categorical data, except male/female, are expressed as count (percentage)
ICA, internal carotid artery; SD, standard deviation, n˚, number;
*, highly significant
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24-hour DUS results
Twenty-four hours after the procedures, the two groups
of this study showed significant increase in luminal dia-
meter of p-ICA versus baseline (Fig. 1). The mean luminal
diameter of p-ICA increased from 3.65 ¡ 2.36 mm to 4.98 ¡
1.36 mm in the carotid artery stenting group (P = 0.00) and
from 3.00 ¡ 2.09 mm to 6.33 ¡ 1.17 mm in the patch closure
group (P = 0.00).
Before stenting, a mean PSV of 244.64 ¡ 109.22 cm/s and a
mean EDV of 97.30 ¡ 72.10 cm/s were measured in the p-
ICA. After stenting, both PSV and EDV of p-ICA were
significantly decreased to the normal range [(mean PSV =
71.64 ¡ 24.08 cm/s; P = 0.00) (mean EDV = 22.07 ¡
10.68 cm/s; P = 0.00)]. In patients undergoing patch closure,
mean PSV and EDV of p-ICA also normalized 24 hours
postoperatively {[PSV = 285.59 ¡ 123.14 cm/s (pre) vs 68.86
¡ 26.66 cm/s (post); P = 0.00] [EDV = 149.31 ¡ 371.35cm/s
(pre) vs 20.57 ¡ 16.37 cm/s (post); P = 0.00]}.
Table 2 shows that no significant differences in luminal
diameter (mm) and PSV (cm/s) measured in CCA and d-
ICA were found between preoperative and postoperative
DUS.
Among carotid artery stenting patients, the mean EDV of
CCA reduced from 26.28 ¡ 28.95 cm/s to 14.37 ¡ 5.28 cm/s
(P = 0.03) after the procedures.
No significant differences in residual stenosis rates were
observed between the stenting group (3 cases, 10.34%) and
the patch closure group (1 case, 1.53%, P = 0.08). One
carotid artery stenting patient presented with 50-69%
residual stenosis in ipsilateral ICA, which had a PSV of
158 cm/s and an EDV of 45 cm/s. In two stenting patients,
the luminal diameter of the stented carotid was narrowest at
24 hours (identified on B-mode imaging), indicating
residual stenosis caused by the presence of calcified plaque
and the suboptimal stent expansion. In the patch closure
group, one patient presented with a distal flap in p-ICA,
which was identified with a PSV of 170 cm/s and an EDV of
65 cm/s; this lesion was repaired with carotid artery
stenting 30 hours postoperatively.
12-month DUS results
The two groups of this study showed significant differ-
ences in luminal diameter of p-ICA when the 24-hour and 12-
month duplex imaging data were compared (Fig. 1). The p-
ICA lumen significantly increased from 4.98 ¡ 1.36 mm to
5.95 ¡ 1.29 mm in the stenting group (P = 0.00). In contrast,
in the patch closure group the lumen of p-ICA reduced from
6.33 ¡ 1.77 mm to 5.59 ¡ 1.19 mm (P = 0.00).
Figure 2 (a-c) shows the mean velocities (hemodynamic
patterns) through the p-ICA, d-ICA and CCA over the
follow-up period. Table 3 shows that the mean velocities
were not significantly different when 24-hour and 12-month
studies were compared.
During the follow-up period, restenoses developed in two
stenting sites (6.88%). One of these was identified with a
PSV of 156 cm/s and an EDV of 46 cm/s; the other
representing the progression of a residual lesion was
identified with a PSV of 410 cm/s and an EDV of 140 cm/
s (the patient died of a stroke before receiving new
intervention). Similarly, two patients in the patch closure
group (3.07%, P = 0.58) also presented with restenosis
during the follow-up period: one patient developed $80%
restenosis in p-ICA (PSV of 328 cm/s and EDV of 120 cm/s)
and underwent subsequent reintervention with stenting; the
other patient presented with a lesion in the CCA (PSV of
180 cm/s and EDV of 60 cm/s), which was associated with
progression of a 40% residual stenosis.
Clinical outcomes
There were no significant differences in ipsilateral stroke
rates between the stenting group and the patch closure
group (6.88% vs 0%, P = 0.09). However, the number of
new TIAs in the stenting group was significantly higher
than the number of new TIAs in the patch closure group
(10.36% vs 0%, P = 0.02). Specifically, two stenting patients
suffered ipsilateral stroke; one of these during the endovas-
cular procedure, the other 12 months postoperatively (the
latter was associated with a 90% restenosis). Three stenting
patients experienced TIA. In one of 3 cases, TIA appeared
during the procedure; the other two cases appeared after a
symptom-free interval of 4- and 9 hours, respectively. In all
cases with TIA, the 24 hour DUS examination indicated
carotid patency, PSV ,125 cm/s and EDV ,40 cm/s.
In one stenting patient, a pseudoaneurysm of the common
femoral artery was discovered during follow-up and
required surgical treatment. In the patch closure group,
one patient developed a neck hematoma that did not require
evacuation.
At 20 months, 2 stenting patients (6.89%) had myocardial
infarction versus 3 patch closure patients (4.61%, P = 0.64).
Kaplan-Meier survival curves show that stenting patients
appeared proportionately more likely to die during follow-
up (Fig. 3). Estimated 20-month survival was 82.2% in the
stenting group and 92.3% in the patch closure group;
however, this apparent trend was not statistically significant
(P = 0.15). Five stenting patients died after the procedure;
one of these deaths occurred during the perioperative
Figure 1 – Luminal diameter (mm) of p-ICA, 1 day before and
24 hours and 12 months after carotid endarterectomy (CEA) and
carotid artery stenting (CAS). Numbers above the bars indicate
the quantitative changes ¡ standard deviations.
p-ICA: proximal internal carotid artery
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1318period (within 30 days) and was not related to the
procedure (cause of death was pulmonary infection). The
other deaths occurred during the late postoperative period:
two because of myocardial infarction (at 10 and 11 months,
respectively), one due to lung cancer (11 months), and one
because of ipsilateral stroke caused by restenosis
Table 2 – Short-term DUS results: Comparison of preoperative and 24h postoperative.
Carotid artery stenting group (n = 29) Patch closure group (n = 65)
95%CI 95%CI
DUS parameters MD SD tP -value lower upper MD SD tP -value lower upper
Proximal ICA
luminal diameter (mm) -1.38 1.63 -4.32 0.00* -1.96 -0.70 -3.32 2.32 -10.42 0.00* -3.97 -2.68
PSV (cm/s) 173.00 110.17 8.30 0.00* 130.27 215.72 216.75 124.38 13.61 0.00* 184.89 248.60
EDV (cm/s) 75.23 0.05 5.46 0.00* 47.61 102.84 128.74 72.23 2.74 0.00* 34.99 222.48
Distal ICA
luminal diameter (mm) -0.07 0.41 -0.93 0.35 -0.20 -0.08 -0.16 0.76 -1.63 0.10 -0.35 -0.03
PSV (cm/s) 8.14 31.23 1.37 0.17 -3.96 20.25 5.27 7.37 1.34 0.18 -2.41 12.95
EDV (cm/s) 0.35 7.69 -0.24 0.80 -3.34 2.62 -0.68 13.52 -0.38 0.69 -4.21 2.84
CCA
luminal diameter (mm) 0.11 0.55 1.10 0.28 -0.09 0.32 -0.05 1.09 -0.36 0.71 -0.32 0.22
PSV (cm/s) 10.96 45.98 1.28 0.21 -6.52 28.45 -2.09 25.35 -0.65 0.51 -8.48 4.29
EDV (cm/s) 11.91 32.53 2.17 0.03{ 0.96 22.85 -2.20 21.58 -0.81 0.41 -7.59 3.18
CCA, common carotid artery; CI, confidence interval; DUS, duplex ultrasound; EDV, end-diastolic velocity; ICA, internal carotid artery; MD, mean
difference; PSV, peak systolic velocity; SD, standard deviation; t, value of the paired t-test.
*, highly significant;
{, significant.
Figure 2 – Mean duplex-velocities (PSV and EDV, cm/s) through the p-ICA (a), d-ICA (b) and CCA (c) over the follow-up period.
PSV: peak systolic velocity; EDV: end diastolic velocity; p-ICA: proximal internal carotid artery; d-ICA: distal internal carotid artery; CCA:
common carotid artery; CAS: carotid artery stenting; CEA: carotid endarterectomy.
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perioperative deaths but there were five postoperative
deaths: one due to contralateral stroke (3 months), three
because of myocardial infarction (2, 14 and 18 months,
respectively), and one caused by pneumonia (20 months).
DISCUSSION
As the clinical application of carotid artery stenting
expands, its safety and durability continues to be evaluated
and compared with carotid endarterectomy which is the
gold-standard treatment.
1-5 Unfortunately, in major trials
comparing carotid artery stenting with endarterectomy,
only the technique for the performance of stenting has been
defined; the technique for endarterectomy has usually been
the surgeon’s customary approach. At present, few studies
have specifically set out to compare stenting and routine
patch closure, although patching is now thought to be part
of the optimal care of patients undergoing traditional
endarterectomy. Randomized prospective trials and meta-
analyses have reported improved rates of perioperative and
mid-term stroke prevention, as well as reduced rates of
restenosis for patches compared with primary arterial
closure; and these favorable results have been attributed
Table 3 – DUS results: Comparison of postoperative day 1 and 12 months.
Carotid artery stenting group (n = 29) Patch closure group (n = 65)
95%CI 95%CI
DUS parameters MD SD tP -value lower upper MD SD tP -value lower upper
Proximal ICA
luminal diameter (mm) -1.09 1.95 -2.85 0.00* -1.88 -0.30 0.64 1.73 2.80 0.00* 0.18 1.10
PSV (cm/s) 1.62 34.38 0.24 0.80 -11.97 15.23 -9.15 60.78 -1.15 0.25 -22.99 6.68
EDV (cm/s) 2.14 18.21 0.61 0.54 -5.05 9.35 -0.54 26.56 -0.15 0.81 -7.46 6.38
Distal ICA
luminal diameter (mm) 0.00 0.56 0.03 0.97 -0.21 0.22 0.10 0.69 1.16 0.24 -0.07 0.29
PSV (cm/s) 0.92 30.85 0.15 0.87 11.28 13.13 1.55 29.05 0.41 0.68 -6.01 9.13
EDV (cm/s) 1.07 9.44 0.59 0.56 -2.66 4.80 0.93 2.11 0.47 0.63 -2.13 3.27
CCA
luminal diameter (mm) 0.24 1.34 0.93 0.36 -0.29 0.77 0.07 1.49 0.39 0.69 -0.31 0.47
PSV (cm/s) -9.77 26.22 -1.93 0.06 -20.15 0.59 3.72 30.56 0.92 0.35 -4.31 11.76
EDV (cm/s) -8.22 23.41 -1.82 0.07 -17.49 1.03 3.93 17.07 1.76 0.08 -0.51 8.38
CCA, common carotid artery; CI, confidence interval; DUS, duplex ultrasound; EDV, end-diastolic velocity; ICA, internal carotid artery; MD, mean
difference; PSV, peak systolic velocity; SD, standard deviation; t, value of the paired t-test.
*, highly significant.
Figure 3 – Kaplan-Meier survival curves. The survival probability at 20 months was 82.8% among patients who received stent (n = 29)
versus 92.3% among those who underwent patch closure (n = 65) (P = 0.15, 95%CI = 0.0949 to 1.4458). Numbers on the graphed lines
indicate the number of patients. CAS: carotid artery stenting; CEA: carotid endarterectomy.
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1320to arterial widening, with a reduction in the effect of intimal
hyperplasia.
6-8,35-40 Our group’s preference is for biological
patches, such as bovine pericardium, because they offer the
benefits of ‘off-the-shelf’ availability, durability and bio-
compatibility.
6,7,35 Bovine pericardial patches have shown
significantly decreased intraoperative suture line bleeding
compared with prosthetic patches.
41 Also, when compared
with outcomes after the use of prosthetic patches, bovine
pericardial patches show a lower incidence of restenosis (4%
vs 7.6%, P ,0.05).
42
The use of bovine pericardium for the patch material (as
used in this study) permits excellent quality DUS, because
both DacronH and polytetrafluoroethylene materials cause
acoustical shadowing and prevent a complete examina-
tion.
43 Previous studies report that patients with carotid
patching with broadened lumen at the bulb presented
statistically elevated turbulent flow disturbances with
increased flow velocity in the ICA, which may adversely
affect the accuracy of DUS scanning.
18,30 However, in the
present study, no measurable flow disturbances in the
absence of a residual stenosis or restenosis were observed.
Mean DUS parameters (luminal diameter, PSV and EDV)
obtained 24 hours and 12 months after patch closure were
indicative of arterial widening and hemodynamics restora-
tion. We believe that the hemodynamic effect from patching
is directly related to the size of the dilated patched vessel,
and bovine 8 mm wide pericardial patch angioplasty (as
used in this study) permits optimization of vessel geometry
and blood flow. In agreement with this, Fietsam et al
44
demonstrated that only a large patch ($10 mm wide)
relative to native vessel dimensions might create marked
flow disturbances throughout the cardiac cycle. Literature
reports, preoperative imaging data, manufacturer data and
observations from previous experience were considered
when standardizing the patch diameter at 8 mm. There were
no occurrences of long-term complications of patches such
as infection or pseudoaneurysm formation in our study.
As a consequence of arterial geometrical remodeling, in
patched carotids, the luminal diameter of p-ICA decreased
in the interval between the 24-hour and 12-month studies. In
contrast, in stented patients, DUS revealed that Wallstents
had expanded after implantation by exerting steady radial
pressure against the arterial wall and that further increase in
luminal diameter might occur over time. A recent DUS
study
29 demonstrated that Wallstents expand over 2 years
and that this expansion is most pronounced in soft plaques,
less so in fibrous plaques and least pronounced in calcified
plaques. The implications of this continuous self-expansion
of the Wallstent on late clinical outcome remain undeter-
mined. In this self-expansion period, our group has
recommended a policy of DUS surveillance and antiplatelet
therapy for prevention of thromboembolic events.
Willfort-Ehringer et al
29 reported that arterial remodeling
after stenting most commonly produced an increase in PSV
from day 1 (75 ¡ 27 cm/s) to 12 months (101 ¡ 37 cm/s, P
,0.001) post-procedure, indicating a segmental arterial
narrowing secondary to neointimal hyperplasia. However,
the results from our study indicate that arterial hemody-
namics (mean PSVs) normalized immediately after stenting
and remained fairly stable, thereafter, up to 12 months. In
this work, stenting was associated with patency and no
statistical evidence of neointimal proliferation exceeding
stent expansion or yielding increased PSV was observed at
12 months post-procedure. These data allow us to speculate
that alterations in the physical properties of the vessel wall
after self-expanding stent placement have no relevant effect
on DUS derived PSV in normal stented carotids.
45 However,
the real effect of stenting on DUS-velocity remains to be
determined in larger scale clinical comparison of various
stent types, as the PSV may be influenced differently
according to the device used, as previously described.
46
Interestingly, stenting was associated with a significant
reduction in EDV of CCA [26.28 ¡ 28.95 cm/s (pre) vs 14.37
¡ 5.28 cm/s (post); P = 0.03] in this study, which could be
secondary to alterations in vessel geometry or arterial wall
biomechanics after stenting. To the best of our knowledge,
no previous clinical study has shown similar results;
therefore the real significance of this hemodynamic altera-
tion remains under investigation.
This study did not support a general approach to new
velocity criteria indiscriminately applied to patched or
stented carotids. Our group has used a native carotid
validated DUS algorithm
14 to confirm carotid patency and
grade residual stenosis and restenosis severity after carotid
artery stenting and patch closure. This algorithm has been
associated with infrequent neurological events. For exam-
ple, B-mode imaging and spectral broadening have routi-
nely been used to supplement our velocity thresholds to
determine stenosis severity. Obviously, data obtained by
individual vascular laboratories will vary due to differences
in equipment, abilities and the consistency of vascular
technician, and the interpretation of the results obtained.
Each vascular laboratory, therefore, must adopt a method
that conforms to the equipment used and validate their
method when performing DUS surveillance after stenting or
patch closure. In this study, all carotids were examined with
a Philips/ATL HDI 5000 scanner (Bothell, WA, USA),
operated by a single registered vascular radiologist.
Regarding DUS examination, no significant differences in
residual stenosis (immediately post-procedure) and rest-
enosis (within of 12 months of procedure) were observed
between the stenting and patch closure groups (P levels =
0.08 and 0.58, respectively). It should be mentioned that in-
stent stenosis was estimated at 6.88%; however, restenoses
in self-expanding stents are reported nearly exclusively
during the first year
29 and we expect better results with a
longer follow-up.
In this study, one single stenting patient suffered late
stroke, which was associated with a 90% restenosis
identified at 12 month DUS examination. Four other
neurologic events (1 stroke and 3 TIA) were reported for
the stenting group, which occurred before the 24 hour DUS
examination; two of these four events (1 stroke and 1 TIA)
occurred during the endovascular procedure, despite the
use of a cerebral protection filter. In all stenting cases with
TIA, the DUS examination indicated carotid patency and
hemodynamic restoration. It is possible that these events are
affected by the indications for stenting: a factor that should
be carefully evaluated by our Service. In the early stages of
this study, new lesions were influenced by anatomical
findings that now represent relative contraindications for
endovascular management, including the angulation of the
aortic arch and severe calcification of the target carotid
stenosis.
There was no evidence of statistically significant differ-
ences in the rate of strokes, myocardial infarctions and
deaths between the groups studied. The number of new
TIAs in the stenting group was significantly higher than the
CLINICS 2010;65(12):1315-1323 DUS of patched vs stented carotids
Morales MM et al.
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however, this study was not large enough to rule out any
advantage or disadvantage of one treatment over the other.
Only large controlled trials or large cohort studies might to
prove an equivalency between stenting and patch closure
(CEA) with sufficient scientific evidence.
One limitation of this work is that it was restricted to a
nonrandomized single-center study; however, the advan-
tage is that it was prospective. The number of cases may
have been too small to reveal differences in residual
stenosis, restenosis and clinical outcomes between stenting
and patch closure; however, the sample size was robust
enough to demonstrate quantitative alterations in morpho-
logical and hemodynamic DUS parameters after stenting
and patch closure.
CONCLUSION
In stented patients, the luminal diameter of the p-ICA
increased in the interval between the 24-hour and 12-month
post-procedure studies, while in the patch closure patients,
thep-ICAdiameterdecreased;signalingdifferencesinarterial
remodeling mechanisms. Carotid hemodynamics normalized
immediately after both patching and stenting and remained
relatively stable, thereafter, up to 12 months. As no
statistically elevated flow velocities in the absence of residual
stenosis or restenosis were observed in this study, our data
did not support a general approach to new velocity criteria
indiscriminately applied to stented or patched carotids.
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